# OnCo record rejuv-frontier-nad-precursors (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/rejuv-frontier-nad-precursors/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "rejuv-frontier-nad-precursors" ;
  schema:name "NAD+ precursors taken by mouth"@en ;
  schema:description "NAD+ falls with age, and swallowing a precursor raises it in the blood. That much is established. Whether raising it does anything for a person who has had cancer is not. The one B3 compound with a real cancer result is plain nicotinamide, for preventing skin cancers in people who keep getting them, which is a different claim entirely."@en ;
  schema:url <https://onco.cc/technologies/rejuv-frontier-nad-precursors/> ;
  schema:dateModified "2026-10-02"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Nicotinamide_riboside> ;
  schema:citation <https://doi.org/10.1038/s41467-023-43514-6>, <https://doi.org/10.1056/NEJMoa1506197> ;
  onco:status "phase-2" ;
  onco:tag "rejuvenation", "survivorship", "evidence:insufficient", "supplement" ;
  onco:related <https://onco.cc/technologies/rejuv-frontier-nad-infusions/> ;
  onco:sections <https://onco.cc/fronts/rejuvenation/>, <https://onco.cc/fronts/supportive-care/> ;
  onco:technologies <https://onco.cc/technologies/survivorship-care-plan/> ;
  onco:drugs <https://onco.cc/drugs/nicotinamide/> ;
  onco:terms <https://onco.cc/terms/late-effects/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-survivorship/> .